Insider Trades85 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 4,000 | $7.52 | $670.0M | -12.36% | +153.87% | $30.1K | -0.68% | — | — |
| Aug 12, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 5,000 | $7.52 | $670.0M | -12.36% | +153.87% | $37.6K | -2.24% | — | — |
| Aug 7, 2026 | Sell | SOPH | Abhimanyu Verma | Chief Technology Officer | 5,000 | $7.60 | $670.0M | -12.36% | +153.87% | $38.0K | -2.67% | — | — |
| Aug 7, 2026 | Sell | SOPH | Jurgi Camblong | Executive Chairman | 28,500 | $7.34 | $670.0M | -12.36% | +153.87% | $209.2K | -0.41% | — | — |
| Aug 5, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 30,000 | $5.92 | $670.0M | -12.36% | +153.87% | $177.7K | -0.33% | — | — |
| Aug 4, 2026 | Sell | SOPH | Abhimanyu Verma | Chief Technology Officer | 5,000 | $6.95 | $670.0M | -12.36% | +153.87% | $34.8K | -2.60% | — | — |
| Aug 4, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 10,000 | $6.92 | $670.0M | -12.36% | +153.87% | $69.2K | -1.64% | — | — |
| Aug 4, 2026 | Sell | SOPH | Jurgi Camblong | Executive Chairman | 20,000 | $6.92 | $670.0M | -12.36% | +153.87% | $138.4K | -0.57% | — | — |
| Jul 27, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 5,000 | $5.66 | $670.0M | -12.36% | +153.87% | $28.3K | -2.19% | — | — |
| Jul 20, 2026 | Sell | SOPH | Jurgi Camblong | Executive Chairman | 48,962 | $6.14 | $670.0M | -12.36% | +153.87% | $300.6K | -0.28% | — | — |
| Jul 13, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 4,000 | $5.70 | $670.0M | -12.36% | +153.87% | $22.8K | -0.65% | — | — |
| Jul 13, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 5,000 | $5.70 | $670.0M | -12.36% | +153.87% | $28.5K | -2.14% | — | — |
| Jul 10, 2026 | Sell | SOPH | Jurgi Camblong | Executive Chairman | 8,500 | $5.62 | $670.0M | -12.36% | +153.87% | $47.8K | -0.24% | — | — |
| Jul 7, 2026 | Sell | SOPH | Jurgi Camblong | Executive Chairman | 17,685 | $5.28 | $670.0M | -12.36% | +153.87% | $93.3K | -0.50% | — | — |
| Jul 6, 2026 | Sell | SOPH | Kevin Puylaert | Chief Sales Officer | 216 | $5.03 | $670.0M | -12.36% | +153.87% | $1.1K | -0.05% | — | — |
| Jul 6, 2026 | Sell | SOPH | George Cardoza | Chief Financial Officer | 1,592 | $5.29 | $670.0M | -12.36% | +153.87% | $8.4K | -0.51% | — | — |
| Jul 6, 2026 | Sell | SOPH | Manuela Valente | Chief People Officer | 4,241 | $5.05 | $670.0M | -12.36% | +153.87% | $21.4K | -1.98% | — | — |
| Jul 6, 2026 | Sell | SOPH | Abhimanyu Verma | Chief Technology Officer | 5,285 | $5.10 | $670.0M | -12.36% | +153.87% | $27.0K | -2.68% | — | — |
| Jul 6, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 7,393 | $5.16 | $670.0M | -12.36% | +153.87% | $38.2K | -3.07% | — | — |
| Jul 6, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 7,393 | $5.17 | $670.0M | -12.36% | +153.87% | $38.2K | -1.19% | — | — |
| Jul 6, 2026 | Sell | SOPH | Ross Muken | Chief Executive Officer | 9,838 | $5.22 | $670.0M | -12.36% | +153.87% | $51.4K | -1.45% | — | — |
| Jul 6, 2026 | Sell | SOPH | Jurgi Camblong | Executive Chairman | 22,486 | $5.25 | $670.0M | -12.36% | +153.87% | $118.2K | -0.63% | — | — |
| Jun 29, 2026 | Sell | SOPH | Jurgi Camblong | Executive Chairman | 147,158 | $4.81 | $670.0M | -12.36% | +153.87% | $707.3K | -0.08% | — | — |
| Jun 25, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 5,000 | $5.50 | $670.0M | -12.36% | +153.87% | $27.5K | -2.03% | — | — |
| Jun 25, 2026 | Sell | SOPH | Abhimanyu Verma | Chief Technology Officer | 6,944 | $5.51 | $670.0M | -12.36% | +153.87% | $38.2K | -3.40% | — | — |
| Jun 25, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 83,382 | $4.79 | $670.0M | -12.36% | +153.87% | $399.1K | -0.13% | — | — |
| Jun 22, 2026 | Sell | SOPH | Ross Muken | President | 422 | $5.38 | $670.0M | -12.36% | +153.87% | $2.3K | -0.06% | — | — |
| Jun 22, 2026 | Sell | SOPH | George Cardoza | Chief Financial Officer | 774 | $5.38 | $670.0M | -12.36% | +153.87% | $4.2K | -0.25% | — | — |
| Jun 15, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 4,000 | $5.01 | $670.0M | -12.36% | +153.87% | $20.1K | -0.64% | — | — |
| Jun 12, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 5,000 | $4.95 | $670.0M | -12.36% | +153.87% | $24.8K | -1.99% | — | — |
| Jun 10, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 8,500 | $5.24 | $670.0M | -12.36% | +153.87% | $44.5K | -0.23% | — | — |
| Jun 5, 2026 | Buy | SOPH | George Cardoza | Chief Financial Officer | 20,000 | $4.95 | $670.0M | -12.36% | +153.87% | $99.0K | +6.86% | — | — |
| May 26, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 5,000 | $4.95 | $670.0M | -12.36% | +153.87% | $24.8K | -1.95% | — | — |
| May 19, 2026 | Sell | SOPH | Kevin Puylaert | Chief Sales Officer | 33 | $4.54 | $670.0M | -12.36% | +153.87% | $149.899 | -0.02% | — | — |
| May 19, 2026 | Sell | SOPH | Manuela Valente | Chief People Officer | 380 | $4.60 | $670.0M | -12.36% | +153.87% | $1.7K | -0.18% | — | — |
| May 19, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 608 | $4.60 | $670.0M | -12.36% | +153.87% | $2.8K | -0.10% | — | — |
| May 19, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 608 | $4.61 | $670.0M | -12.36% | +153.87% | $2.8K | -0.24% | — | — |
| May 19, 2026 | Sell | SOPH | Well Daan Van | Chief Legal Officer | 684 | $4.60 | $670.0M | -12.36% | +153.87% | $3.1K | -0.20% | — | — |
| May 19, 2026 | Sell | SOPH | Ross Muken | President | 761 | $4.60 | $670.0M | -12.36% | +153.87% | $3.5K | -0.11% | — | — |
| May 19, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 4,486 | $4.60 | $670.0M | -12.36% | +153.87% | $20.7K | -0.12% | — | — |
| May 13, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 4,000 | $4.54 | $670.0M | -12.36% | +153.87% | $18.2K | -0.63% | — | — |
| May 12, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 5,000 | $4.67 | $670.0M | -12.36% | +153.87% | $23.3K | -1.91% | — | — |
| May 11, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 8,500 | $5.09 | $670.0M | -12.36% | +153.87% | $43.2K | -0.23% | — | — |
| Apr 27, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 5,000 | $4.82 | $670.0M | -12.36% | +153.87% | $24.1K | -1.88% | — | — |
| Apr 20, 2026 | Sell | SOPH | Kevin Puylaert | Chief Sales Officer | 33 | $5.08 | $670.0M | -12.36% | +153.87% | $167.693 | -0.02% | — | — |
| Apr 20, 2026 | Sell | SOPH | Manuela Valente | Chief People Officer | 380 | $5.20 | $670.0M | -12.36% | +153.87% | $2.0K | -0.18% | — | — |
| Apr 20, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 608 | $5.20 | $670.0M | -12.36% | +153.87% | $3.2K | -0.23% | — | — |
| Apr 20, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 608 | $5.21 | $670.0M | -12.36% | +153.87% | $3.2K | -0.10% | — | — |
| Apr 20, 2026 | Sell | SOPH | Well Daan Van | Chief Legal Officer | 684 | $5.20 | $670.0M | -12.36% | +153.87% | $3.6K | -0.20% | — | — |
| Apr 20, 2026 | Sell | SOPH | Ross Muken | President | 760 | $5.20 | $670.0M | -12.36% | +153.87% | $4.0K | -0.11% | — | — |
| Apr 20, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 4,486 | $5.21 | $670.0M | -12.36% | +153.87% | $23.3K | -0.12% | — | — |
| Apr 14, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 600 | $4.97 | $670.0M | -12.36% | +153.87% | $3.0K | -0.09% | — | — |
| Apr 14, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 1,600 | $4.96 | $670.0M | -12.36% | +153.87% | $7.9K | -0.60% | — | — |
| Apr 14, 2026 | Sell | SOPH | Ross Muken | President | 2,800 | $4.96 | $670.0M | -12.36% | +153.87% | $13.9K | -0.41% | — | — |
| Apr 14, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 60,602 | $4.97 | $670.0M | -12.36% | +153.87% | $301.2K | -0.82% | — | — |
| Apr 10, 2026 | Sell | SOPH | Well Daan Van | Chief Legal Officer | 2,400 | $4.67 | $670.0M | -12.36% | +153.87% | $11.2K | -0.69% | — | — |
| Apr 10, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 8,120 | $4.73 | $670.0M | -12.36% | +153.87% | $38.4K | -0.42% | — | — |
| Apr 10, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 8,125 | $4.73 | $670.0M | -12.36% | +153.87% | $38.4K | -0.99% | — | — |
| Apr 10, 2026 | Sell | SOPH | Ross Muken | President | 8,129 | $4.73 | $670.0M | -12.36% | +153.87% | $38.4K | -0.59% | — | — |
| Apr 10, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 16,631 | $4.73 | $670.0M | -12.36% | +153.87% | $78.7K | -0.15% | — | — |
| Apr 8, 2026 | Sell | SOPH | George Cardoza | Chief Financial Officer | 1,403 | $4.85 | $670.0M | -12.36% | +153.87% | $6.8K | -0.48% | — | — |
| Apr 8, 2026 | Sell | SOPH | Manuela Valente | Chief People Officer | 3,824 | $4.85 | $670.0M | -12.36% | +153.87% | $18.5K | -1.74% | — | — |
| Apr 8, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 4,731 | $4.80 | $670.0M | -12.36% | +153.87% | $22.7K | -0.84% | — | — |
| Apr 8, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 4,736 | $4.80 | $670.0M | -12.36% | +153.87% | $22.7K | -0.37% | — | — |
| Apr 8, 2026 | Sell | SOPH | Ross Muken | President | 4,736 | $4.80 | $670.0M | -12.36% | +153.87% | $22.7K | -0.34% | — | — |
| Apr 8, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 4,750 | $4.80 | $670.0M | -12.36% | +153.87% | $22.8K | -0.06% | — | — |
| Apr 8, 2026 | Sell | SOPH | Well Daan Van | Chief Legal Officer | 4,849 | $4.80 | $670.0M | -12.36% | +153.87% | $23.3K | -0.69% | — | — |
| Apr 6, 2026 | Sell | SOPH | Kevin Puylaert | Chief Sales Officer | 624 | $4.86 | $670.0M | -12.36% | +153.87% | $3.0K | -0.14% | — | — |
| Apr 6, 2026 | Sell | SOPH | Abhimanyu Verma | Chief Technology Officer | 3,549 | $4.86 | $670.0M | -12.36% | +153.87% | $17.3K | -0.86% | — | — |
| Apr 6, 2026 | Sell | SOPH | George Cardoza | Chief Financial Officer | 4,933 | $4.86 | $670.0M | -12.36% | +153.87% | $24.0K | -0.83% | — | — |
| Apr 6, 2026 | Sell | SOPH | Manuela Valente | Chief People Officer | 4,973 | $4.86 | $670.0M | -12.36% | +153.87% | $24.1K | -1.12% | — | — |
| Apr 6, 2026 | Sell | SOPH | Ross Muken | President | 5,024 | $4.86 | $670.0M | -12.36% | +153.87% | $24.4K | -0.36% | — | — |
| Apr 6, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 5,100 | $4.86 | $670.0M | -12.36% | +153.87% | $24.8K | -0.07% | — | — |
| Apr 6, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 5,100 | $4.86 | $670.0M | -12.36% | +153.87% | $24.8K | -0.89% | — | — |
| Apr 6, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 5,100 | $4.86 | $670.0M | -12.36% | +153.87% | $24.8K | -0.39% | — | — |
| Apr 6, 2026 | Sell | SOPH | Well Daan Van | Chief Legal Officer | 5,105 | $4.86 | $670.0M | -12.36% | +153.87% | $24.8K | -0.71% | — | — |
| Mar 31, 2026 | Sell | SOPH | Kevin Puylaert | Chief Sales Officer | 3 | $4.71 | $670.0M | -12.36% | +153.87% | $14.13 | -0.00% | — | — |
| Mar 19, 2026 | Sell | SOPH | Kevin Puylaert | Chief Sales Officer | 33 | $4.76 | $670.0M | -12.36% | +153.87% | $157.08 | -0.04% | — | — |
| Mar 19, 2026 | Sell | SOPH | Manuela Valente | Chief People Officer | 380 | $4.79 | $670.0M | -12.36% | +153.87% | $1.8K | -0.25% | — | — |
| Mar 19, 2026 | Sell | SOPH | Zhenyu Xu | Chief Scientific Officer | 608 | $4.78 | $670.0M | -12.36% | +153.87% | $2.9K | -0.11% | — | — |
| Mar 19, 2026 | Sell | SOPH | Philippe Menu | Chief Medical Officer | 608 | $4.79 | $670.0M | -12.36% | +153.87% | $2.9K | -0.35% | — | — |
| Mar 19, 2026 | Sell | SOPH | Well Daan Van | Chief Legal Officer | 684 | $4.79 | $670.0M | -12.36% | +153.87% | $3.3K | -0.26% | — | — |
| Mar 19, 2026 | Sell | SOPH | George Cardoza | Chief Financial Officer | 774 | $4.79 | $670.0M | -12.36% | +153.87% | $3.7K | -0.42% | — | — |
| Mar 19, 2026 | Sell | SOPH | Ross Muken | President | 1,183 | $4.79 | $670.0M | -12.36% | +153.87% | $5.7K | -0.43% | — | — |
| Mar 19, 2026 | Sell | SOPH | Jurgi Camblong | Chief Executive Officer | 4,486 | $4.77 | $670.0M | -12.36% | +153.87% | $21.4K | -0.14% | — | — |